Ignite Creation Date:
2024-05-06 @ 3:45 PM
Last Modification Date:
2024-10-26 @ 1:56 PM
Study NCT ID:
NCT04747236
Status:
RECRUITING
Last Update Posted:
2024-06-26
First Post:
2021-02-03
Brief Title:
Randomized Phase IIB Trial of Oral Azacytidine Plus Romidepsin Versus Investigators Choice in PTCL
Sponsor:
University of Virginia
Organization:
University of Virginia
Organization Data
Organization:
University of Virginia
Class:
OTHER
Study ID:
PTCL-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Virginia
Lead Sponsor Class:
OTHER
Responsible Party:
Enrica Marchi MD
Responsible Party Title:
Assistant Professor Department of Medicine Hematology and Oncology
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
University of Virginia
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Celgene | INDUSTRY |